We are live on ! Find out more
TGAN

Transphorm, Inc. Common Stock
TGAN

Delisted

TGAN was delisted on the 20th of June, 2024.

Back to rankings

0 hedge funds and large institutions have $0 invested in Transphorm, Inc. Common Stock in 2024 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 57 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 57 → 0 (-57)

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

100% less capital invested

Capital invested by funds: $203M → $0 (-$203M)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 57

Holders
–
Holders Change
-57
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
57
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

1
KKRC
Kohlberg Kravis Roberts & Co
New York
-$120M
2
Ameriprise
Ameriprise
Minnesota
-$23.2M
3
AAM
Alpine Associates Management
Florida
-$12.1M
4
BlackRock
BlackRock
New York
-$8.64M
5
Vanguard Group
Vanguard Group
Pennsylvania
-$7.37M
Name Holding Trade Value Shares
Change 		Change in
Stake
WIC
26
Water Island Capital
New York
– -$236K -48,157 Closed
GC
27
Guggenheim Capital
Illinois
– -$232K -47,284 Closed
Citadel Advisors
28
Citadel Advisors
Florida
– -$213K -43,286 Closed
SO
29
STRS Ohio
Ohio
– -$190K -38,700 Closed
RhumbLine Advisers
30
RhumbLine Advisers
Massachusetts
– -$155K -31,663 Closed
N
31
Nuveen
North Carolina
– -$149K -30,360 Closed
PCM
32
Prelude Capital Management
New York
– -$119K -24,243 Closed
Deutsche Bank
33
Deutsche Bank
Germany
– -$106K -21,528 Closed
Barclays
34
Barclays
United Kingdom
– -$103K -20,957 Closed
VF
35
Virtu Financial
New York
– -$84K -17,064 Closed
MIM
36
MetLife Investment Management
New Jersey
– -$83.7K -17,053 Closed
QC
37
Quadrature Capital
United Kingdom
– -$76.1K -15,539 Closed
AIG
38
American International Group
New York
– -$72.5K -14,773 Closed
GI
39
GAMCO Investors
Connecticut
– -$59.9K -12,200 Closed
Bank of America
40
Bank of America
North Carolina
– -$51.4K -10,464 Closed
SWP
41
Stratos Wealth Partners
Ohio
– -$50.1K -10,203 Closed
Wells Fargo
42
Wells Fargo
California
– -$43.7K -8,900 Closed
New York State Common Retirement Fund
43
New York State Common Retirement Fund
New York
– -$31.6K -6,440 Closed
Citigroup
44
Citigroup
New York
– -$24.3K -4,945 Closed
TRCT
45
Tower Research Capital (TRC)
New York
– -$15.8K -3,217 Closed
Fidelity Investments
46
Fidelity Investments
Massachusetts
– -$15.6K -3,172 Closed
Legal & General Group
47
Legal & General Group
United Kingdom
– -$15.4K -3,129 Closed
California State Teachers Retirement System (CalSTRS)
48
California State Teachers Retirement System (CalSTRS)
California
– -$14.8K -3,014 Closed
Royal Bank of Canada
49
Royal Bank of Canada
Ontario, Canada
– -$10K -2,156 Closed
MLICM
50
Metropolitan Life Insurance Company (MetLife)
New York
– -$8.89K -1,811 Closed
1
2
3

TGAN Hedge Fund Activity: Q2 2024 in Review

0 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Transphorm, Inc. Common Stock (TGAN) for Q2 2024, worth a combined $0 — down 100% from $203M a quarter earlier.

Sellers outnumbered buyers: 57 funds closed out of TGAN and 0 opened new positions — a net loss of 57 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Kohlberg Kravis Roberts & Co, exiting entirely with an estimated $120M sold.

  • 0 institutional investors held Transphorm, Inc. Common Stock (TGAN) as of Q2 2024, down from 57 in Q1 2024.
  • Funds reported $0 of Transphorm, Inc. Common Stock stock for Q2 2024, down 100% quarter-over-quarter.
  • 0 funds opened new Transphorm, Inc. Common Stock positions in Q2 2024 and 57 closed out, a net change of -57 holders.
  • The largest Transphorm, Inc. Common Stock seller in Q2 2024 was Kohlberg Kravis Roberts & Co, an estimated $120M sold.

Based on aggregated 13F filings for Q2 2024.